2/M |
Frontal lobe |
II |
0 |
Normal karyotype |
|
NA |
Negative |
|
Negative |
|
1/M |
Frontal lobe |
II |
0 |
Normal karyotype |
|
NA |
Negative |
Negative (IHC) |
Negative |
MGMT not methylated |
10/F |
Frontal lobe |
II |
0 |
Normal karyotype |
|
NA |
Negative |
Negative (IHC) |
|
|
13/M |
Frontal lobe |
II |
0 |
No somatic alterations |
5q33.3, 16q24.1qtel(CNN), 20qcenq11.23(CNN) |
NA |
|
|
Negative |
|
19/F |
Temporal lobe |
II |
0 |
del 1p (whole arm), del 19q (whole arm) |
CN‐LOH 2q33.3q35, CN‐LOH 11q22.3q22.3(CNN), |
Chr 1p (FUBP1), 19q (CIC) |
|
|
Positive |
|
1/M |
Parietal lobe |
II |
0 |
Normal karyotype |
|
NA |
|
|
|
|
1/M |
Frontal lobe |
II |
0 |
Normal karyotype |
|
NA |
|
|
|
|
8/F |
Temporal lobe |
II |
0 |
del8p23.1p23.1, del8p21.2p12, del8q13.2q13.3, del8q22.1q23.1 |
13q |
|
Negative |
Negative (IHC) |
Negative |
|
15/M |
Temporal lobe |
II |
0 |
LOH 1q (whole arm) |
22q13.1q13.2 |
22q (germ line XRCC6, RANGAP1, SGSM3,MKL1, ST13,DNAJB7, TEF, TOB2, NHP2L1, SREBF2, CENPM, TNFRSF13C, CYP2D6, TCF20, CYP2D7P1, RBX1, MIR4766, MIR1281, and MCHR1. ) |
|
|
Negative |
|
9/F |
Brain |
II |
0 |
Gain whole Chr7, LOH 9ptelp21.3, del9p21.3p21.3 (Homozygous), LOH 9p21.3p13.3 |
6p22.1p22.1, 6q22.2q22.31; 12p13.2p13.1, 12q23.1q23.3 |
Ch 7 (EGFR, MET, HGF, BRAF), 9p (CDKN2A, CDKN2B, CDKN2BAS, C9orf53, MTAP) |
|
|
|
|
1/M |
brainstem |
II |
0 |
chr22q13.1 |
5q23.3q31.2; 12q24.11q24.13 |
DDX17, CSNK1E, DNC1, CBY1, SUN2, CBX6, CBX7, PDGFB |
|
|
Negative |
|
2/F |
Parietal lobe |
II |
0 |
Normal karyotype |
|
NA |
Negative |
Negative (IHC) |
Negative |
|
16/M |
Frontal lobe |
II |
0 |
del 1p (whole arm), del 19q (whole arm) |
|
FUBP1, CIC |
|
|
Negative |
|
4/M |
Medial temporal |
II |
0 |
ND |
|
NA |
|
|
Negative |
|
14/M |
Frontal lobe |
II |
0 |
del 16p13.11p12.3, LOH 17p (whole arm) |
|
Chr 17p (TP53) |
|
|
|
|
12/M |
Temporal lobe |
II |
0 |
ND |
|
NA |
Negative |
Negative (IHC) |
Negative |
Negative for 1p19q LOH (STR) |
2/M |
Frontal lobe |
II |
0 |
ND |
|
NA |
Negative |
|
Negative |
Negative for 1p19q LOH (STR) |
16/M |
Parietal lobe |
II |
0 |
ND |
|
NA |
Negative |
Negative (IHC) |
Positive |
|
11/M |
Posterior fossa |
II |
0 |
Gain whole Chr6, Chr7, Chr8, Chr11, Chr12 |
|
Ch 7 (EGFR, MET, HGF, BRAF), FGFR1 |
Negative |
Negative (PCR) |
|
Negative for 1p19q LOH (STR) |
19/M |
Frontal lobe |
II |
0 |
ND |
|
NA |
|
|
Negative |
1p19q loss (STR) |
16/M |
Frontal lobe |
III |
0 |
LOH 3q12.1q26.31, LOH 3q29qtel, LOH 4p (whole arm), dup4q12q13.1, CN‐LOH 4q13.1qtel, del6ptelp21.3, del6p21.3p21.31 (small population subset), del11ptelp15.3, LOH 12q (whole arm), del13q (whole arm), CN‐LOH 17ptelp11.2, LOH 18p (whole arm), del18q (near whole arm), LOH 21q (whole arm) |
|
Chr 11p (CDKN1C, NUP98, SLC22A18), 13q (RB1), 17p (TP53), Chr 18 (DCC) |
|
Negative (PCR) |
Negative |
MGMT methylated |
11/F |
Frontal lobe |
III |
0 |
del 1p (whole arm), LOH 1q (whole arm), del 2 (whole Chr deletion), del 3ptelp21.1, del 3q29qtel, del6ptelp22.3, del9ptelp13.2, LOH 9q21.33qtel, del 11ptelp15.1, del 14q21.3qtel, del 15q24.3qtel, del 17ptelp11.2, CN‐LOH 17q22qtel, heterogeneous whole Ch18 loss, del 19q (whole arm), gain X (whole Chr) |
22q13.1q13.2 |
Chr 1p (FUBP1), 11p (CDKN1C, NUP98, SLC22A18), 19q (CIC), 17p(TP53), Chr 18 (DCC), 22q(germ line XRCC6, RANGAP1, SGSM3,MKL1, ST13,DNAJB7, TEF, TOB2, NHP2L1, SREBF2, CENPM, TNFRSF13C, CYP2D6, TCF20, CYP2D7P1, RBX1, MIR4766, MIR1281, and MCHR1) |
|
|
|
|
17/F |
Frontal lobe |
III |
Chemotherapy and radiation 10 years prior for leukemia with CNS involvement |
del 1p (whole arm), CN‐LOH 1qcentq25.2, del 4q21.1qtel, del 13q (whole arm), del14q23.3qtel, gain 17q23.2qtel |
|
Chr 1p (FUBP1), Chr 13 (RB1) |
|
|
|
|
3/M |
cerebellum |
III |
RT+Chemo |
del 1ptelp36.23, gain 1p36.23p36.13, gain 1p36.12p36.11, del 1p36.11cent, del 2q22.3p23.1, del 3q26.32qtel, del 6q23.3q25.1, del 8ptelp23.2, del 9ptelp13.1, del 10q26.3qtel, del 11p15.4p11.2, gain 12q12q13.11, gain 12q13.13q13.2, gain 12q13.2q13.3, gain 12q14.1q15, del 16q12.1qtel, del 19q12q13.11, del 19q13.13qtel, del 20p (whole arm) |
|
12q (CDK4, MDM2) |
|
|
Negative |
|
10/F |
Parietal lobe |
III |
0 |
del17qcentq21.33, CN‐LOH 17q22q24.2(CNN), del17q24.3qtel |
|
NF1 |
Negative |
|
Negative |
|
18/F |
Frontal lobe |
III |
0 |
ND |
|
NA |
Negative |
|
Positive |
1p19q loss (STR) |
7/M |
Frontal lobe |
III |
0 |
ND |
|
NA |
Negative |
|
Negative |
Negative for 1p19q LOH (STR) |
11/M |
Occipital lobe |
III |
0 |
ND |
|
NA |
Negative |
|
Negative |
Negative for 1p19q LOH (STR) |